Hypoactive Sexual Desire Disorder in Women: Treatment Options Beyond Testosterone and Approaches to Communicating with Patients on Sexual Health

2013 ◽  
Vol 33 (4) ◽  
pp. 411-421 ◽  
Author(s):  
Nicole M. Lodise
Keyword(s):  
Sexual Health ◽  
Sexual Desire ◽  
Treatment Options ◽  
Hypoactive Sexual Desire Disorder ◽  
Desire Disorder

scholarly journals International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women

2021 ◽  
Vol 30 (4) ◽  
pp. 474-491
Author(s):  
Sharon J. Parish ◽  
James A. Simon ◽  
Susan R. Davis ◽  
Annamaria Giraldi ◽  
Irwin Goldstein ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Sexual Health ◽  
International Society ◽  
Clinical Practice Guideline ◽  
Sexual Desire ◽  
Practice Guideline ◽  
Hypoactive Sexual Desire Disorder ◽  
Women’S Sexual Health ◽  
Desire Disorder

Treatments for Hypoactive Sexual Desire Disorder (HSDD) and the Pursuit of Sexual Health for Women amidst Inglorious Rhetoric

2018 ◽  
Vol 6 (3) ◽  
pp. 339-342
Author(s):  
Noel N. Kim ◽  
Irwin Goldstein ◽  
Lisa Larkin ◽  
Susan Kellogg-Spadt ◽  
James A. Simon
Keyword(s):  
Sexual Health ◽  
Sexual Desire ◽  
Hypoactive Sexual Desire Disorder ◽  
Desire Disorder

scholarly journals Pharmacologic Treatment Options for Hypoactive Sexual Desire Disorder

2005 ◽  
Vol 1 (2) ◽  
pp. 263-277 ◽  
Author(s):  
Sheila Y Bolour ◽  
Glenn D Braunstein
Keyword(s):  
Sexual Desire ◽  
Treatment Options ◽  
Sex Therapy ◽  
Pharmacologic Treatment ◽  
Hypoactive Sexual Desire Disorder ◽  
Common Cause ◽  
Low Sexual Desire ◽  
Herbal Therapies ◽  
Phosphodiesterase 5 ◽  
Desire Disorder

Hypoactive sexual desire disorder is the most common cause of sexual dysfunction in women. According to a national survey, approximately a third of all women experience low sexual desire. The etiology of the disorder is often multifactorial. Research in treatment options for hypoactive sexual desire disorder is limited. In this article, treatment options including sex therapy, hormone therapy (estrogen, testosterone, dehydroepiandrosterone, tibolone), non-hormonal medical therapies (buproprion, buspirone, phosphodiesterase-5 inhibitors, amantadine and apomorphine) and herbal therapies (Avlimil®, Arginmax®, Zestra®, yohimbine and Ginkgo biloba) are reviewed.

scholarly journals The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women

2018 ◽  
Vol 93 (4) ◽  
pp. 467-487 ◽  
Author(s):  
Anita H. Clayton ◽  
Irwin Goldstein ◽  
Noel N. Kim ◽  
Stanley E. Althof ◽  
Stephanie S. Faubion ◽  
...  
Keyword(s):  
Sexual Health ◽  
International Society ◽  
Sexual Desire ◽  
Hypoactive Sexual Desire Disorder ◽  
Process Of Care ◽  
Women’S Sexual Health ◽  
Health Process ◽  
Desire Disorder
Sign in / Sign up

Export Citation Format

Share Document